PLAT and Hyperglycemia: Moreover, in IS patients receiving intravenous tissue plasminogen activator (tPA) therapy, hyperglycemia has been linked to reduced rates of recanalization and an increased risk of hemorrhagic transformation, further heightening the chances of mortality [24–28].